Categories
| Category | |
|---|---|
| Health Conditions and Concerns | 30% |
| Medicine | 20% |
| Health | 20% |
| Others | 30% |
Explore sites in same category:
- ogorimii-med.net Rank 1.4M. Estimated value 1,512$
- ocrahope.org Rank 781.7K. Estimated value 2,760$
- myvision.org Rank 439.1K. Estimated value 4,932$
- gluten.org Rank 887.9K. Estimated value 2,424$
- veri.co Rank 646.5K. Estimated value 3,336$
- kesimpta.com Rank 1.3M. Estimated value 1,668$
- dr-hips.com Rank 1M. Estimated value 2,232$
- ito-jibika.net Rank 1.1M. Estimated value 1,968$
- presspogo.com Rank 663.9K. Estimated value 3,252$
- myeczemateam.com Rank 1.5M. Estimated value 1,392$
Keyword Suggestion
Domain Informations
Ocrevus.com lookup results from whois.safenames.net server:
- Domain created: 2014-02-26T08:56:08Z
- Domain updated: 2024-03-01T04:16:49Z
- Domain expires: 2026-02-26T08:56:08Z 1 Year, 303 Days left
- Website age: 10 Years, 61 Days
- Registrar Domain ID: 1848247509_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.10.122
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.10.122)
Spam Check (IP: 104.18.10.122)
Websites Listing
We found Websites Listing below when search with ocrevus.com on Search Engine
Contact Your Genentech Representative | OCREVUS® …
There is a pregnancy exposure registry that monitors pregnancy and fetal/neonatal/infant outcomes in women exposed to OCREVUS during pregnancy. Physicians are encouraged to register patients and pregnant women are encouraged to register themselves by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
Ocrevus-hcp.comSign-up for Patient Support and Resources - ocrevus
Nausea. headache. swelling of the throat. dizziness. shortness of breath. fatigue. fast heart beat. These infusion reactions can happen for up to 24 hours after your infusion. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion.
Ocrevus.comOCREVUS® (ocrelizumab) Sitemap | Official HCP Site
There is a pregnancy exposure registry that monitors pregnancy and fetal/neonatal/infant outcomes in women exposed to OCREVUS during pregnancy. Physicians are encouraged to register patients and pregnant women are encouraged to register themselves by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
Ocrevus-hcp.comReimbursement & Billing Codes | OCREVUS® (ocrelizumab)
DESCRIPTION. 96413. Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug. 96415. Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) 96365. Intravenous infusion, for therapy, prophylaxis, or diagnosis ...
Ocrevus-hcp.com2022 OCREVUS MS Events: In-Person & Online Options from …
See OCREVUS risks and benefits. Genentech follows current CDC guidelines and recommends that you are fully vaccinated to attend a live in person Speaker Program. We suggest you plan on attending a virtual program if you are not fully vaccinated. M-US-00013127(v2.0) OCREVUS Patient Education Events. Join us in person or virtually to learn more about relapsing multiple …
Ocrevusevents.comSign Up for OCREVUS® (ocrelizumab) Updates for HCPs
There is a pregnancy exposure registry that monitors pregnancy and fetal/neonatal/infant outcomes in women exposed to OCREVUS during pregnancy. Physicians are encouraged to register patients and pregnant women are encouraged to register themselves by calling 1-833-872-4370 or visiting www.ocrevuspregnancyregistry.com.
Ocrevus-hcp.comNew data for Roche’s OCREVUS (ocrelizumab) show benefit in
2022-04-04 · About OCREVUS (ocrelizumab) OCREVUS is the first and only therapy approved for both RMS (including RRMS, active SPMS and CIS in the U.S.) and PPMS, with six-month dosing. OCREVUS is a humanised ...
Globenewswire.comRoche - Login
Welcome to the OCREVUS patient website. This website is intended only for patients who have been prescribed OCREVUS. It contains information about your condition, treatment with OCREVUS, patient support program as well as important safety information. Please contact your healthcare team if you have any questions about OCREVUS or if you have any ...
Myocrevus.com.auSee posts, photos and more on Facebook.
Facebook.comNo Increased Risk Found From Ocrevus Exposure in Pregnancy
2022-03-25 · Ocrevus is an MS antibody therapy, marketed by Genentech, that is approved for relapsing forms of the disease and for primary progressive MS. The treatment, given intravenously (into the vein ...
Multiplesclerosisnewstoday.com5 MS Patients Talk About How Ocrevus Has Changed Their Lives
2018-04-17 · 5 MS Patients Across US Talk About How Ocrevus Has Changed Their Lives. Lorraine Lee, who has PPMS, on a visit to Thailand. (Photo courtesy of Lorraine Lee) It’s been a little over a year since ...
Multiplesclerosisnewstoday.com#AAN2022 – MS Trial Update Shows Ocrevus' Effectiveness After 1 …
2022-04-07 · by Marisa Wexler, MS April 7, 2022. Nearly three of every four participants in the CONSONANCE clinical trial, which is evaluating Ocrevus (ocrelizumab) in people with …
Multiplesclerosisnewstoday.comNew Data for Genentech’s Ocrevus (ocrelizumab) Show Benefit in ...
2022-04-04 · SOUTH SAN FRANCISCO, Calif., April 04, 2022--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new Ocrevus® (ocrelizumab) data that show its benefit on disease ...
Finance.yahoo.comOcrevus Reduces MS Relapse Risk, But Linked to More …
2021-08-25 · In terms of efficacy, Ocrevus was found to effectively reduce relapse rates among relapsing MS patients, with the participants exhibiting an ARR of 0.09, compared with 0.34 at two years (24 months ...
Multiplesclerosisnewstoday.comPrescription & Enrollment Form Ocrevus (ocrelizumab) - Accredo
Ocrevus ® (ocrelizumab) Four simple steps to submit your referral. ... E-mail address. Parent/guardian (if applicable) Home phone . Cell phone . E-mail address. Alternate caregiver/contact . Home phone . Cell phone . E-mail address. English . Other . If other, please specify . 2 . Prescriber Information. All fields must be completed to expedite prescription …
Accredo.comOcrevus vs Kesimpta? : MultipleSclerosis
Advice. Hi everyone! I was diagnosed this week with RRMS. I have a few lesions on my brain and a few on my c-spine with suspected lesions also on my t-spine (waiting for another MRI next week to confirm those). The specialist I saw suspects that I’ve had MS for about a year and wants to start me on either Ocrevus or Kesimpta next month.
Reddit.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| sigmasearch.in | porkbun.com | -1 Years, -201 Days |
| heritagerestaurant.info | publicdomainregistry.com | -2 Years, -44 Days |
| golia.net | publicdomainregistry.com | -1 Years, -21 Days |
| etatpur.com | nameshield.net | -2 Years, -79 Days |
| olenofarm.com | dreamhost.com | -1 Years, -355 Days |
| advancedfilerecovery.com | publicdomainregistry.com | 2 Years, 48 Days |
| glyanec.net | imena.ua | -2 Years, -41 Days |
| bonddata.org | easyspace.com | 21 Days |
| pipkins.com | networksolutions.com | 5 Years, 208 Days |
| biggreentrain.com | tucows.com | -1 Years, -298 Days |